Loading your page…
Leukemia, Myeloid, Acute
Marketing Authorisation Holder: Pfizer Europe MA EEIG
EMA Authorisation: 26/06/2020
INN: glasdegib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Daurismo: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
